Subscribe today so you get these insights first. Szyman, currently Corporate Vice President and General Manager of Critical Care at Edwards Lifesciences. At the higher end of the proposed range, OM would command a fully diluted market value. Outset Medical, Inc., a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysis, today announced the appointment of Katie Szyman to its board of directors. Hundreds of subscribers have already listened to this podcast. Outset Medical (OM) plans to raise 180M at a price range of 22 to 24. Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of. This week’s Newmarker’s Newsmakers including Hologic, Varian, Smith+Nephew, Avail Medsystems and Outset Medical. You’ll also get a rundown of the Top 5 Medtech Stories from Chris Newmarker, executive editor of MassDevice. Outset Medical Inc employs 444 staff and has a trailing 12-month revenue of around 110.1 million. ![]() Its last market close was 42.8 an increase of 11.68 over the previous week. Outset Medical Inc stocks (OM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Hear those points and an interview with Doug Teany, COO of Corindus Vascular Robotics, in this week’s DeviceTalks Weekly Podcast. Outset Medical Inc is a medical devices business based in the US. Trigg also sees the pandemic’s pushing more patients toward out-of-clinic care, creating potential tailwinds for Outset and Tablo. The COVID-19 pandemic not only created a new - and perhaps more efficient way - of raising capital. But Trigg credits the team she assembled for helping the start-up develop a bolder, more comprehensive strategy to change how dialysis is delivered in clinical and home settings.ģ. Outset initially had more modest goals in establishing Tablo as an alternative to traditional dialysis centers. She offered a few insights and tips on how to make virtual calls most effective.Ģ. While admitting she was disappointed that Outset executives couldn’t conduct a traditional in-person roadshow, Trigg said meeting public investors via Zoom calls was an effective way to assemble investors. Outset Medical is a pioneering medical technology company that manufactures medical equipment. In this week’s DeviceTalks Weekly Podcast, Trigg shared several key points, including:ġ. The company will use the capital to roll out its Tablo hemodialysis system. (Nasdaq: OM) (Outset) today announced the closing of its initial public offering of 10,293,777 shares of its common stock, including the exercise in full by the underwriters' option to purchase 1,342,666 additional shares of common stock, at the initial public offering price of 27.00 per share. Under the IPO, the company has issued the 8,951,111 shares of its common stock at a public offering price of USD27.00 per share for total gross proceeds of approximately USD241.7m, before deducting underwriting discounts and commissions and offering expenses. Tablo is a mobile integrated hemodialysis solution for acute and home. This week, in her first stint as a CEO, Trigg led Outset Medical to an IPO, raising $278 million. is a medical technology company that offers Tablo. Before that she held senior positions at Lutonix, AccessClosure and FoxHollow, helping to position those companies to be acquired by CR Bard, Cardinal Health, and ev3/Covidien, respectively. Our relentless focus on flexibility, ease of use and user experience translates to meaningfully reduced training times and fixed infrastructure requirements.Outset Medical (NSDQ: OM) CEO Leslie Trigg took the helm at the dialysis start-up in 2013, moving from an executive-in-residence post at private equity firm Warburg Pincus. Our technology is designed to elevate the dialysis experience for patients, and help providers overcome traditional care delivery challenges. ![]() We designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. ![]() We believe Tablo represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |